                               SEQUENCE LISTING

<110> THE UNIVERSITY OF TOLEDO
 
<120> XENOANTIGEN-CONTAINING LIPOPEPTIDE VACCINES

<130> 53-58515/D2017-06

<140>
<141>

<150> 62/399,762
<151> 2016-09-26

<160> 20    

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Tetanus toxoid epitope

<400> 1
Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15  


<210> 2
<211> 14
<212> PRT
<213> Neisseria meningitidis

<400> 2
Lys Leu Phe Ala Val Trp Lys Ile Thr Tyr Lys Asp Thr Gly 
1               5                   10                  


<210> 3
<211> 20
<212> PRT
<213> Neisseria meningitidis

<400> 3
Tyr Ala Phe Lys Tyr Ala Arg His Ala Asn Val Gly Arg Asn Ala Phe 
1               5                   10                  15      


Glu Leu Phe Leu 
            20  


<210> 4
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Epitope derived from ovalbumin

<400> 4
Ile Ser Gln Ala Val His Ala Ala His Ala Glu Ile Asn Glu Ala Gly 
1               5                   10                  15      


Arg 
    


<210> 5
<211> 12
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Pan DR epitope


<220>
<221> MOD_RES
<222> (1)..(1)
<223> D-Ala 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> L-cyclohexylalanine 

<220>
<221> MOD_RES
<222> (12)..(12)
<223> D-Ala 

<400> 5
Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala 
1               5                   10          


<210> 6
<211> 14
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 6
Gly Thr Thr Met Val Ser Tyr Gln Pro Leu Gly Asp Lys Val 
1               5                   10                  


<210> 7
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 7
Ser Tyr Gln Pro Leu Gly Asp Lys Val 
1               5                   


<210> 8
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 8
Ser Tyr Gln Pro Leu Gly Asp Ala Val 
1               5                   


<210> 9
<211> 14
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 9
Gly Thr Thr Met Val Ser Tyr Gln Pro Leu Gly Asp Ala Val 
1               5                   10                  


<210> 10
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 10
Ser Tyr Gln Pro Leu Gly Asp Lys Ala 
1               5                   


<210> 11
<211> 14
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Diabetic peptide sequence

<400> 11
Gly Thr Thr Met Val Ser Tyr Gln Pro Leu Gly Asp Lys Ala 
1               5                   10                  


<210> 12
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro Ala His Gly 
1               5                   10                  15      


Val Thr Ser Ala 
            20  


<210> 13
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro Pro 
1               5                   10                  15      


Ala His Gly Val 
            20  


<210> 14
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Ser Lys Lys Lys Lys 
1               5   


<210> 15
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Pro Asp Thr Arg Pro 
1               5   


<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Cys Ser Lys Lys Lys Lys 
1               5       


<210> 17
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 6-azido hexanoic acid 

<400> 17
Xaa Thr Ser Ala Pro Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala Pro 
1               5                   10                  15      


Pro Ala His Gly Val 
            20      


<210> 18
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 6-azido hexanoic acid 

<400> 18
Xaa Ser Tyr Gln Pro Leu Gly Asp Lys Val 
1               5                   10  


<210> 19
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 6-azido hexanoic acid 

<400> 19
Xaa Gly Thr Thr Met Val Ser Tyr Gln Pro Leu Gly Asp Ala Val 
1               5                   10                  15  


<210> 20
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> 6-azido hexanoic acid 

<400> 20
Xaa Thr Ser Ala Pro His Asp Thr Arg Pro Ala Pro Gly Ser Thr Ala 
1               5                   10                  15      


Pro Pro Ala His Gly Val 
            20          


